Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $70.93 USD
Change Today +0.51 / 0.72%
Volume 105.8K
As of 8:10 PM 04/20/15 All times are local (Market data is delayed by at least 15 minutes).

magellan health inc (MGLN) Snapshot

Open
$70.71
Previous Close
$70.42
Day High
$71.30
Day Low
$70.54
52 Week High
04/2/15 - $71.77
52 Week Low
10/7/14 - $52.37
Market Cap
1.9B
Average Volume 10 Days
132.6K
EPS TTM
$3.22
Shares Outstanding
27.3M
EX-Date
--
P/E TM
22.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for MAGELLAN HEALTH INC (MGLN)

magellan health inc (MGLN) Related Bloomberg News

View More Bloomberg News

magellan health inc (MGLN) Related Businessweek News

No Related Businessweek News Found

magellan health inc (MGLN) Details

Magellan Health, Inc. engages in the healthcare management business in the United States. The company’s Managed Healthcare Commercial segment offers managed behavioral healthcare services, as well as employee assistance programs services. Its Managed Healthcare Public Sector segment is involved in the management of behavioral health services for recipients under contracts with state and local governmental agencies; and integrated management of physical, behavioral, and pharmaceutical care for special populations covered under Medicaid and other government sponsored programs. The company’s Specialty Solutions segment provides specialty solutions, such as the delivery of diagnostic imaging and various other specialty areas comprising radiation oncology, obstetrical ultrasound, cardiology, and musculoskeletal management. This segment offers specialty solutions under contracts with health plans and insurance companies for its commercial, Medicaid, and Medicare members. Its Pharmacy Management segment provides pharmacy management products and solutions that offer clinical and financial management of drugs paid under medical and pharmacy benefit programs, including traditional pharmacy benefit management (PBM); pharmacy benefit administration for state Medicaid and other government sponsored programs; specialty pharmaceutical dispensing operations, and contracting and formulary optimization programs; medical pharmacy management programs; and programs for the management of specialty drugs, which treat complex conditions, as well as subcontract arrangements to provide PBM services for public sector customers. The company offers its services to health plans, managed care organizations, employers, labor unions, various military and governmental agencies, third party administrators, consultants, brokers, and insurance companies. Magellan Health, Inc. was founded in 1969 and is based in Scottsdale, Arizona.

6,600 Employees
Last Reported Date: 02/26/15
Founded in 1969

magellan health inc (MGLN) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $975.0K
Chief Financial Officer
Total Annual Compensation: $496.8K
Chief Executive Officer of Magellan Healthcar...
Total Annual Compensation: $518.8K
Chief Executive Officer of National Imaging A...
Total Annual Compensation: $450.9K
General Counsel and Secretary
Total Annual Compensation: $430.2K
Compensation as of Fiscal Year 2014.

magellan health inc (MGLN) Key Developments

Magellan Health, Inc. Reports Earnings Results for the Fourth Quarter and Year Ended December 31, 2014; Re-Affirms Earnings Guidance for the Year 2015

Magellan Health, Inc. reported earnings results for the fourth quarter and year ended December 31, 2014. For the quarter, the company reported income attributable to the company for the fourth quarter ended December 31, 2014 was $21.56 million, or $0.82 per common diluted share, compared to $18.49 million, or $0.67 per common diluted share, for the same quarter ended December 31, 2013. Total net revenue for the fourth quarter ended December 31, 2014 was $982.46 million, compared to $1.01 billion for the same quarter ended December 31, 2013. Net income attributable to the company for the year ended December 31, 2014 was $79.4 million, or $2.9 per common diluted share, compared to $125.26 million, or $4.53 per common diluted share, for the year ended December 31, 2013. Total net revenue for the year ended December 31, 2014 was $3.76 billion, compared to $3.55 billion for the year ended December 31, 2013. The company maintaining 2015 ranges discussed in December guidance call for net revenue in the range of $4.25 billion to $4.49 billion, net income of $51 million to $67 million, adjusted net income of $88 million to $100 million, and segment profit of $265 million to $285 million. The company also maintaining guidance for cash flow from operations in the range of $171 million to $195 million. Guidance range for fully diluted EPS is estimated to be $1.93 to $2.54 and for fully diluted adjusted EPS of $3.33 to $3.79.

Magellan Health, Inc. Announces the Contract with Louisiana Department of Health and Hospitals

Magellan Health, Inc. had a contract with the Louisiana Department of Health and Hospitals to manage behavioral health care for Medicaid recipients and other beneficiaries through the Louisiana Behavioral Health Partnership. The Current Contract, which generated annual revenue of approximately $150 million, expired on February 28, 2015. On March 2, 2015, the company and the Louisiana Department entered into a new emergency contract with terms through November 30, 2015. The emergency contract will cover services substantially the same as the current contract.

Magellan Health, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Reiterates Earnings Guidance for the Year 2015

Magellan Health, Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported net profit attributable to company of $21.6 million or $0.82 per basic and diluted share on revenue of $982.5 million compared to net profit attributable to company of $18.5 million or $0.67 per diluted share on total revenue of $1,008.2 million reported in the same period last year. Income before income taxes was $35.05 million against $28.4 million reported last year. Adjusted net income was $35.0 million or $1.33 per share against $19.9 million or $0.72 per share reported last year. For the year, the company reported net profit attributable to company of $79.4 million or $2.90 per basic and diluted share on revenue of $3,760.1 million compared to net profit attributable to company of $125.3 million or $4.53 per diluted share on total revenue of $3,546.3 million reported in the same period last year. Income before income taxes was $117.9 million against $165.2 million reported last year. Adjusted net income was $110.6 million or $4.04 per share against $126.7 million or $4.58 per share reported last year. Net cash provided by operating activities was $211.0 million against $183.2 million reported last year. Capital expenditures were $62.3 million against $64.5 million reported last year. Relative to 2015, the company is maintaining the ranges discussed in December guidance call for net revenue in the range of $4.25 billion to $4.49 billion, net income of $51 million to $67 million, adjusted net income of $88 million to $100 million, and segment profit of $265 million to $285 million. The company is also maintaining its guidance for cash flow from operations in the range of $171 million to $195 million. Taking into account the impact of share repurchase activity through February 23, 2015, but not considering any potential future share repurchases, guidance range for fully diluted EPS is estimated to be $1.93 to $2.54 and for fully diluted adjusted EPS of $3.33 to $3.79. These EPS ranges are based on 26.4 million average fully diluted shares.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MGLN:US $70.93 USD +0.51

MGLN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amsurg Corp $65.16 USD +0.63
Kindred Healthcare Inc $23.76 USD +0.08
LifePoint Hospitals Inc $75.96 USD +0.47
Select Medical Holdings Corp $14.77 USD +0.17
Universal American Corp/NY $10.58 USD -0.23
View Industry Companies
 

Industry Analysis

MGLN

Industry Average

Valuation MGLN Industry Range
Price/Earnings 24.3x
Price/Sales 0.5x
Price/Book 1.7x
Price/Cash Flow 11.3x
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MAGELLAN HEALTH INC, please visit www.magellanhealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.